158 related articles for article (PubMed ID: 11263438)
1. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.
Thunberg U; Johnson A; Roos G; Thörn I; Tobin G; Sällström J; Sundström C; Rosenquist R
Blood; 2001 Mar; 97(6):1892-4. PubMed ID: 11263438
[No Abstract] [Full Text] [Related]
2. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia.
Matrai Z; Lin K; Dennis M; Sherrington P; Zuzel M; Pettitt AR; Cawley JC
Blood; 2001 Mar; 97(6):1902-3. PubMed ID: 11263445
[No Abstract] [Full Text] [Related]
3. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin V genes and CD38 expression in CLL.
Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
[No Abstract] [Full Text] [Related]
5. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
6. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
[TBL] [Abstract][Full Text] [Related]
7. CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.
Vigano A; Saresella M; Villa ML; Ferrante P; Clerici M
Chem Immunol; 2000; 75():207-17. PubMed ID: 10851786
[No Abstract] [Full Text] [Related]
8. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
[TBL] [Abstract][Full Text] [Related]
9. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
[No Abstract] [Full Text] [Related]
11. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
[TBL] [Abstract][Full Text] [Related]
12. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
16. A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes.
Zocchi E; Franco L; Guida L; Benatti U; Bargellesi A; Malavasi F; Lee HC; De Flora A
Biochem Biophys Res Commun; 1993 Nov; 196(3):1459-65. PubMed ID: 8250903
[TBL] [Abstract][Full Text] [Related]
17. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
[TBL] [Abstract][Full Text] [Related]
18. Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia.
Degan M; Rupolo M; Bo MD; Stefanon A; Bomben R; Zucchetto A; Canton E; Berretta M; Nanni P; Steffan A; Ballerini PF; Damiani D; Pucillo C; Attadia V; Colombatti A; Gattei V
Clin Lymphoma; 2004 Sep; 5(2):123-6. PubMed ID: 15453928
[TBL] [Abstract][Full Text] [Related]
19. Is chronic lymphocytic leukemia one disease?
Hamblin T
Haematologica; 2002 Dec; 87(12):1235-8. PubMed ID: 12495893
[No Abstract] [Full Text] [Related]
20. CD38: an 'orphan' protein that may be finding a home?
Felgar RE
Leuk Res; 2000 Feb; 24(2):161-2. PubMed ID: 10654452
[No Abstract] [Full Text] [Related]
[Next] [New Search]